In Bellaire, TX, residents can expect a new vaccine option for the upcoming respiratory illness season. The FDA has approved Moderna's mRNA seasonal flu vaccine, known as mFLUSIVA. This vaccine is intended for individuals aged 50 and older. It is slated to be available for the 2026-2027 season. Further information about mFLUSIVA can be found through ABC13 Houston, the source of this update.